Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments
Math. Model. Nat. Phenom., 4 3 (2009) 12-67
Published online: 2009-06-05
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Selected aspects of avascular tumor growth reproduced by a hybrid model of cell dynamics and chemical kinetics
Marco SciannaMathematical Biosciences 370 109168 (2024)
https://doi.org/10.1016/j.mbs.2024.109168
Optimal administration strategy in chemotherapy regimens using multi-drug cell-cycle specific tumor growth models
Parak Qods, Jamal Arkat and Yazdan BatmaniBiomedical Signal Processing and Control 86 105221 (2023)
https://doi.org/10.1016/j.bspc.2023.105221
AML consolidation therapy: timing matters
Adrian-Manuel Reimann, Enrico Schalk, Felix Jost, Dimitrios Mougiakakos, Daniela Weber, Hartmut Döhner, Christian Récher, Pierre-Yves Dumas, Marc Ditzhaus, Thomas Fischer and Sebastian SagerJournal of Cancer Research and Clinical Oncology 149 (15) 13811 (2023)
https://doi.org/10.1007/s00432-023-05115-0
Do we really understand how drug eluted from stents modulates arterial healing?
Alistair McQueen, Javier Escuer, Ankush Aggarwal, et al.International Journal of Pharmaceutics 601 120575 (2021)
https://doi.org/10.1016/j.ijpharm.2021.120575
Mathematical Modelling of p53 Signalling during DNA Damage Response: A Survey
Ján Eliaš and Cicely K. MacnamaraInternational Journal of Molecular Sciences 22 (19) 10590 (2021)
https://doi.org/10.3390/ijms221910590
Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia
Felix Jost, Enrico Schalk, Kristine Rinke, et al.PLOS ONE 14 (7) e0204540 (2019)
https://doi.org/10.1371/journal.pone.0204540
Growth of adult spinal cord in knifefish: Development and parametrization of a distributed model
Iulian Ilieş, Rifat Sipahi and Günther K.H. ZupancJournal of Theoretical Biology 437 101 (2018)
https://doi.org/10.1016/j.jtbi.2017.10.012
(2018)
https://doi.org/10.1101/428326
Application of mathematical models to metronomic chemotherapy: What can be inferred from minimal parameterized models?
Urszula Ledzewicz and Heinz SchättlerCancer Letters 401 74 (2017)
https://doi.org/10.1016/j.canlet.2017.03.021
Mathematical Modeling of Biofilm Structures Using COMSTAT Data
Davide Verotta, Janus Haagensen, Alfred M. Spormann and Katherine YangComputational and Mathematical Methods in Medicine 2017 1 (2017)
https://doi.org/10.1155/2017/7246286
Blood Cell Dynamics: Half of a Century of Modelling
L. Pujo-Menjouet and V. VolpertMathematical Modelling of Natural Phenomena 11 (1) 92 (2016)
https://doi.org/10.1051/mmnp/201611106
Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation
Rebecca H. Chisholm, Tommaso Lorenzi and Jean ClairambaultBiochimica et Biophysica Acta (BBA) - General Subjects 1860 (11) 2627 (2016)
https://doi.org/10.1016/j.bbagen.2016.06.009
Physiologically Structured Cell Population Dynamic Models with Applications to Combined Drug Delivery Optimisation in Oncology
J. Clairambault, O. Fercoq, G. Bocharov, J. Clairambault and V. VolpertMathematical Modelling of Natural Phenomena 11 (6) 45 (2016)
https://doi.org/10.1051/mmnp/201611604
Optimization of Cytostatic Leukemia Therapy in an Advection–Reaction–Diffusion Model
Chahrazed Benosman, Bedr’Eddine Aïnseba and Arnaud DucrotJournal of Optimization Theory and Applications 167 (1) 296 (2015)
https://doi.org/10.1007/s10957-014-0667-7
Model-Based Tumor Growth Dynamics and Therapy Response in a Mouse Model of De Novo Carcinogenesis
Charalambos Loizides, Demetris Iacovides, Marios M. Hadjiandreou, et al.PLOS ONE 10 (12) e0143840 (2015)
https://doi.org/10.1371/journal.pone.0143840
Catalog of the optimal controls in cancer chemotherapy for the Gompertz model depending on PK/PD and the integral constraint
Luis A. Fernández and Cecilia PolaDiscrete & Continuous Dynamical Systems - B 19 (6) 1563 (2014)
https://doi.org/10.3934/dcdsb.2014.19.1563
The p53 protein and its molecular network: Modelling a missing link between DNA damage and cell fate
Ján Eliaš, Luna Dimitrio, Jean Clairambault and Roberto NataliniBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1844 (1) 232 (2014)
https://doi.org/10.1016/j.bbapap.2013.09.019
The dynamics of p53 in single cells: physiologically based ODE and reaction–diffusion PDE models
Ján Eliaš, Luna Dimitrio, Jean Clairambault and Roberto NataliniPhysical Biology 11 (4) 045001 (2014)
https://doi.org/10.1088/1478-3975/11/4/045001
Synchronisation and control of proliferation in cycling cell population models with age structure
Frédérique Billy, Jean Clairambaultt, Olivier Fercoq, et al.Mathematics and Computers in Simulation 96 66 (2014)
https://doi.org/10.1016/j.matcom.2012.03.005
Mathematical Modeling of Tumor Growth, Drug-Resistance, Toxicity, and Optimal Therapy Design
Marios M. Hadjiandreou and Georgios D. MitsisIEEE Transactions on Biomedical Engineering 61 (2) 415 (2014)
https://doi.org/10.1109/TBME.2013.2280189
Designing proliferating cell population models with functional targets for control by anti-cancer drugs
Frédérique Billy and Jean ClairambaultDiscrete & Continuous Dynamical Systems - B 18 (4) 865 (2013)
https://doi.org/10.3934/dcdsb.2013.18.865
Mathematical Methods and Models in Biomedicine
Frédérique Billy, Jean Clairambault and Olivier FercoqLecture Notes on Mathematical Modelling in the Life Sciences, Mathematical Methods and Models in Biomedicine 265 (2013)
https://doi.org/10.1007/978-1-4614-4178-6_10
Can theorems help treat cancer?
Jean ClairambaultJournal of Mathematical Biology 66 (7) 1555 (2013)
https://doi.org/10.1007/s00285-012-0518-9
Integrative physical oncology
Haralampos Hatzikirou, Arnaud Chauviere, Amy L. Bauer, André Leier, Michael T. Lewis, Paul Macklin, Tatiana T. Marquez‐Lago, Elaine L. Bearer and Vittorio CristiniWIREs Systems Biology and Medicine 4 (1) 1 (2012)
https://doi.org/10.1002/wsbm.158
Optimal control for selected cancer chemotherapy ODE models: A view on the potential of optimal schedules and choice of objective function
Michael Engelhart, Dirk Lebiedz and Sebastian SagerMathematical Biosciences 229 (1) 123 (2011)
https://doi.org/10.1016/j.mbs.2010.11.007
Strain- and Sex-Dependent Circadian Changes in Abcc2 Transporter Expression: Implications for Irinotecan Chronotolerance in Mouse Ileum
Alper Okyar, Enza Piccolo, Constance Ahowesso, et al.PLoS ONE 6 (6) e20393 (2011)
https://doi.org/10.1371/journal.pone.0020393
Optimizing Cancer Pharmacotherapeutics Using Mathematical Modeling and a Systems Biology Approach
Jean ClairambaultPersonalized Medicine 8 (3) 271 (2011)
https://doi.org/10.2217/pme.11.20
Circadian Timing in Cancer Treatments
Francis Lévi, Alper Okyar, Sandrine Dulong, Pasquale F. Innominato and Jean ClairambaultAnnual Review of Pharmacology and Toxicology 50 (1) 377 (2010)
https://doi.org/10.1146/annurev.pharmtox.48.113006.094626
Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics
Jean-Louis Steimer, Svein G. Dahl, Dinesh P. De Alwis, et al.European Journal of Cancer 46 (1) 21 (2010)
https://doi.org/10.1016/j.ejca.2009.10.011